Your browser doesn't support javascript.
loading
Inhibition of checkpoint kinase 1 potentiates anticancer activity of gemcitabine in bladder cancer cells.
Isono, Makoto; Okubo, Kazuki; Asano, Takako; Sato, Akinori.
Affiliation
  • Isono M; Department of Urology, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan. mktisn@hotmail.com.
  • Okubo K; Department of Urology, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
  • Asano T; Department of Urology, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
  • Sato A; Department of Urology, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
Sci Rep ; 11(1): 10181, 2021 05 13.
Article in En | MEDLINE | ID: mdl-33986399
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Pyrimidines / Urinary Bladder Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Deoxycytidine / Checkpoint Kinase 1 / Antimetabolites, Antineoplastic Limits: Animals / Humans Language: En Journal: Sci Rep Year: 2021 Document type: Article Affiliation country: Japan Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Pyrimidines / Urinary Bladder Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Deoxycytidine / Checkpoint Kinase 1 / Antimetabolites, Antineoplastic Limits: Animals / Humans Language: En Journal: Sci Rep Year: 2021 Document type: Article Affiliation country: Japan Country of publication: United kingdom